LIS Technologies Inc. Receives a Non-possessing Facility Clearance from the Nuclear Regulatory Commission Paving a Path for Access to Classified Matter

Oak Ridge, Tennessee, March 27, 2025 (GLOBE NEWSWIRE) — LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, today announced that it has received a non-possessing Facility Clearance from the Nuclear Regulatory Commission (NRC). This allows the Company to apply […]

LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer

(NASDAQ:LIXT),(NASDAQ:LIXTW), -Started Two New Clinical Trials, Collaborating with MD Anderson and The Netherlands Cancer Institute for Treatment of Ovarian and Colorectal Cancer- -Received Exclusive Patent License Agreement with the NIH on LB-100's Potential in Enhancing Cancer Immunotherapies- -Two Breakthrough Publications in Medical Journals, EMBO and Cancer Discovery,Supporting LIXTE's Clinical Trial Program- PASADENA, Calif, March 27,

Nightfood Holdings (NGTF) Issues Shareholder Update on Imminent Strategic Acquisitions and Rapid Expansion in AI-Powered Hospitality Automation

(OTCQB:NGTF),(OTC US:NGTF), TARRYTOWN, NY, March 27, 2025 (GLOBE NEWSWIRE) — via IBN — Nightfood Holdings, Inc. (OTCQB: NGTF) is revolutionizing the hospitality industry by combining artificial intelligence (AI)-powered robotics with strategic hotel acquisitions and is excited to update shareholders on significant imminent milestones in its strategic expansion. The team is working diligently to finalize the

Chemomab Reports Positive Results in Nebokitug Phase 2 PSC Open Label Extension Trial Showing Continued Broad and Substantial Improvements in Key Liver Biomarkers

(NASDAQ:CMMB), Reinforces potential of nebokitug to become the first approved drug with disease-modifying activity for PSC–a deadly disorder that currently has no effective treatments Treatment in PSC patients with moderate/advanced disease for 48 weeks resulted in continued improvements across key biomarkers of liver injury, inflammation and fibrosis, including ELF score, fibrosis-related ELF score components and

SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System

(Other OTC:SSII),(OTC US:SSII), The SSI Mantra 3 Surgical Robotic System enabled a seamless connection from SS Innovations headquarters in Gurugram, India to Aster CMI Hospital in Bengaluru, India covering a distance over 2,000 km. The SSi Mantra, India's first CDSCO*-approved surgical robotic system for telesurgery, brings precision and accessibility to complex surgical procedures. FORT LAUDERDALE,

PSV Ventures Expands Portfolio Investment in Vocodia Holdings

(PinkSheets:VHAI), NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) — PSV Ventures (“PSV”) announced today that it has increased its holdings in Vocodia Holdings Corp (OTC: VHAI) through additional open-market purchases over the past four months. The additional shares were acquired as a method of lowering PSV Ventures' overall cost basis since the issuer's Initial Public

FibroBiologics Announces 2025 Annual Meeting of Stockholders

(NasdaqGM:FBLG), HOUSTON, March 27, 2025 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that its 2025 Annual Meeting of Stockholders will take place on

Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress

(NYSE MKT:OGEN), SARASOTA, Fla., March 27, 2025 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related conditions, today provided shareholders with an update on its strategic and financial progress for the first quarter of 2025. The Company has made meaningful advancements across regulatory, clinical, financial,

Fuel Tech Awarded Air Pollution Control Orders Totaling $1.4 Million

(NASDAQ:FTEK), WARRENVILLE, Ill., March 27, 2025 (GLOBE NEWSWIRE) — Fuel Tech, Inc. (NASDAQ: FTEK), a technology company using advanced engineering processes to provide emissions control systems and water treatment technologies in utility and industrial applications, today announced the receipt of air pollution control (APC) orders from new and existing customers in the US and Europe.

Nxu, Inc. Announces 1-for-20 Reverse Stock Split

(NASDAQ:NXU), MESA, Ariz., March 27, 2025 (GLOBE NEWSWIRE) — Nxu, Inc., (NASDAQ: NXU) (“Nxu”, “the Company”), a domestic technology company focused on energy storage and charging solutions for the infrastructure we need to power our electrified future, today announced a planned reverse stock split of its shares of Class A common stock (the “common stock”)

Scroll to Top